174 related articles for article (PubMed ID: 12387361)
21. Physostigmine (alone and together with adjunct) pretreatment against soman, sarin, tabun and VX intoxication.
Harris LW; Talbot BG; Lennox WJ; Anderson DR; Solana RP
Drug Chem Toxicol; 1991; 14(3):265-81. PubMed ID: 1935706
[TBL] [Abstract][Full Text] [Related]
22. Minimum effective drug concentrations of a transdermal patch system containing procyclidine and physostigmine for prophylaxis against soman poisoning in rhesus monkeys.
Cho Y; Kim WS; Hur GH; Ha YC
Environ Toxicol Pharmacol; 2012 Jan; 33(1):1-8. PubMed ID: 22051905
[TBL] [Abstract][Full Text] [Related]
23. Toxicokinetics of the nerve agent (+/-)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration.
van der Schans MJ; Lander BJ; van der Wiel H; Langenberg JP; Benschop HP
Toxicol Appl Pharmacol; 2003 Aug; 191(1):48-62. PubMed ID: 12915103
[TBL] [Abstract][Full Text] [Related]
24. Evidence for nonacetylcholinesterase targets of organophosphorus nerve agent: supersensitivity of acetylcholinesterase knockout mouse to VX lethality.
Duysen EG; Li B; Xie W; Schopfer LM; Anderson RS; Broomfield CA; Lockridge O
J Pharmacol Exp Ther; 2001 Nov; 299(2):528-35. PubMed ID: 11602663
[TBL] [Abstract][Full Text] [Related]
25. Reactivation of brain acetylcholinesterase by monoisonitrosoacetone increases the therapeutic efficacy against nerve agents in guinea pigs.
Skovira JW; O'Donnell JC; Koplovitz I; Kan RK; McDonough JH; Shih TM
Chem Biol Interact; 2010 Sep; 187(1-3):318-24. PubMed ID: 20230808
[TBL] [Abstract][Full Text] [Related]
26. The effect of pyridostigmine pretreatment on oxime efficacy against intoxication by soman or VX in rats.
Anderson DR; Harris LW; Woodard CL; Lennox WJ
Drug Chem Toxicol; 1992; 15(4):285-94. PubMed ID: 1459041
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of biperiden and atropine as anticonvulsant treatment for organophosphorus nerve agent intoxication.
Shih TM; McDonough JH
Arch Toxicol; 2000 May; 74(3):165-72. PubMed ID: 10877003
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the efficacy of two carbamates, physostigmine and pyridostigmine, when used in conjunction for protection against organophosphate exposure.
Solana RP; Gennings C; Carter WH; Anderson D; Lennox WJ; Carchman RA; Harris LW
Fundam Appl Toxicol; 1990 Nov; 15(4):814-9. PubMed ID: 2086320
[TBL] [Abstract][Full Text] [Related]
29. Effects of 4-pyridine aldoxime on nerve agent-inhibited acetylcholinesterase activity in guinea pigs.
Shih TM; Skovira JW; McDonough JH
Arch Toxicol; 2009 Dec; 83(12):1083-9. PubMed ID: 19763542
[TBL] [Abstract][Full Text] [Related]
30. Organophosphorus nerve agents-induced seizures and efficacy of atropine sulfate as anticonvulsant treatment.
Shih TM; McDonough JH
Pharmacol Biochem Behav; 1999 Sep; 64(1):147-53. PubMed ID: 10495009
[TBL] [Abstract][Full Text] [Related]
31. Timing of decontamination and treatment in case of percutaneous VX poisoning: a mini review.
Joosen MJ; van der Schans MJ; Kuijpers WC; van Helden HP; Noort D
Chem Biol Interact; 2013 Mar; 203(1):149-53. PubMed ID: 23085122
[TBL] [Abstract][Full Text] [Related]
32. A novel approach to assessing percutaneous VX poisoning in the conscious guinea-pig.
Mumford H; Price ME; Wetherell JR
J Appl Toxicol; 2008 Jul; 28(5):694-702. PubMed ID: 18059069
[TBL] [Abstract][Full Text] [Related]
33. Toxicity and median effective doses of oxime therapies against percutaneous organophosphorus pesticide and nerve agent challenges in the Hartley guinea pig.
Snider TH; Babin MC; Jett DA; Platoff GE; Yeung DT
J Toxicol Sci; 2016; 41(4):511-21. PubMed ID: 27432237
[TBL] [Abstract][Full Text] [Related]
34. Non-enzymatic pretreatment of nerve agent (soman) poisoning: a brief state-of-the-art review.
van Helden HP; Joosen MJ; Philippens IH
Toxicol Lett; 2011 Sep; 206(1):35-40. PubMed ID: 21554933
[TBL] [Abstract][Full Text] [Related]
35. Effect of acute physostigmine-hyoscine pretreatment on the neurochemical changes produced by soman in the guinea-pig.
Fosbraey P; Wetherell JR; French MC
Neurochem Int; 1991; 18(2):265-73. PubMed ID: 20504702
[TBL] [Abstract][Full Text] [Related]
36. Control of nerve agent-induced seizures is critical for neuroprotection and survival.
Shih TM; Duniho SM; McDonough JH
Toxicol Appl Pharmacol; 2003 Apr; 188(2):69-80. PubMed ID: 12691725
[TBL] [Abstract][Full Text] [Related]
37. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
38. Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposure.
Haigh JR; Adler M; Apland JP; Deshpande SS; Barham CB; Desmond P; Koplovitz I; Lenz DE; Gordon RK
Chem Biol Interact; 2010 Sep; 187(1-3):416-20. PubMed ID: 20144889
[TBL] [Abstract][Full Text] [Related]
39. Protection by sustained release of physostigmine and procyclidine of soman poisoning in rats.
Choi EK; Park D; Yon JM; Hur GH; Ha YC; Che JH; Kim J; Shin S; Jang JY; Hwang SY; Seong YH; Kim DJ; Kim JC; Kim YB
Eur J Pharmacol; 2004 Nov; 505(1-3):83-91. PubMed ID: 15556140
[TBL] [Abstract][Full Text] [Related]
40. Bioscavenger is effective as a delayed therapeutic intervention following percutaneous VX poisoning in the guinea-pig.
Mann TM; Price ME; Whitmore CL; Perrott RL; Laws TR; McColm RR; Emery ER; Tattersall JEH; Green AC; Rice H
Toxicol Lett; 2018 Sep; 293():198-206. PubMed ID: 29183815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
